Results 111 to 120 of about 216,461 (262)

Single‐Step Synthesis of Dithieno[3,2‐b:2′,3′‐e]Pyridines and Their Acid‐Dependent Optical and Photosensitising Properties

Chemistry – A European Journal, EarlyView.
The synthesis of dithieno[3,2‐b:2′,3′‐e]pyridines (DTPs) is herein reported, and their optical properties are studied both experimentally and computationally. Protonation or methylation of the nitrogen atom induced bathochromic shifts in their absorption and emission spectra.
Dominic Taylor, Matthew Wallace, Leonardo Amicosante, Gary S. Nichol, Scott J. Dalgarno, Filipe Vilela, Iain A. Wright, Neil B. McKeown   +7 more
wiley   +1 more source

(341) California [PDF]

, 2003
openaire   +1 more source

Bluish-green pleural effusion. [PDF]

Lung India
Dixit R, Mathur S.
europepmc   +1 more source

Economic and environmental implications of the development of UASB reactors in Mexico for sustainable industrial wastewater treatment

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract The objective of this work is to demonstrate that the inclusion of an up‐flow anaerobic sludge bed (UASB reactor) within an industrial wastewater treatment plant reduces the plant's investment and operating costs compared to a system based solely on conventional complete‐mix activated sludge (CMAS), operating under the same design principles ...
Juan Manuel Morgan‐Sagastume, Adalberto Noyola   +1 more
wiley   +1 more source

Bacteriological quality, antimicrobial resistance profile of Escherichia coli, and associated risk factors in tap water, Addis Ababa, Ethiopia. [PDF]

Sci Rep
Kassa DF, Bedada TL, Abera D, Getaneh A, Andaga KD, Tesema TF, Legese MH.   +6 more
europepmc   +1 more source

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

Clinical Pharmacology &Therapeutics, EarlyView.
Parkinsonian disorders, including Parkinson's disease, Lewy body dementia, multiple system atrophy, and progressive supranuclear palsy, are progressive neurodegenerative conditions with no treatment options to slow disease progression. This systematic review provides an overview of evidence of disease‐modifying therapies that have been evaluated in ...
Pepijn P.N.M. Eijsvogel, Lars M.G. Smits, Philip H.C. Kremer, Geert Jan Groeneveld   +3 more
wiley   +1 more source

Erratum to "Exploring the universal healthy human gut microbiota around the World". [PDF]

Comput Struct Biotechnol J
Piquer-Esteban S, Ruiz-Ruiz S, Arnau V, Diaz W, Moya A.   +4 more
europepmc   +1 more source

Ten‐Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme

Clinical Pharmacology &Therapeutics, EarlyView.
Biologic therapies are a major and growing driver of pharmaceutical expenditure globally, with tumor necrosis factor (TNF) inhibitors among the most widely used and costly biologics. In Australia, these therapies are funded through the Pharmaceutical Benefits Scheme (PBS), where biosimilars offer lower cost alternatives; however, the long‐term public ...
Chin Hang Yiu, Bella D. Ianni, Richard O. Day, Jacques Raubenheimer, Christine Y. Lu   +4 more
wiley   +1 more source

The myofibrillar myopathy-linked variant DES-p.T341P impairs desmin filament assembly. [PDF]

Mol Biol Rep
Lütkemeyer A, Voß S, Klag F, Groß J, Reckmann J, Gärtner A, Anselmetti D, Gummert J, Walhorn V, Milting H, Brodehl A.   +10 more
europepmc   +1 more source

Payload‐Based Clinical Pharmacology Review of Approved Antibody–Drug Conjugates: Commonalities and Considerations for Streamlined Development

Clinical Pharmacology &Therapeutics, EarlyView.
Antibody–drug conjugates (ADCs) combine the specificity of an antibody with the potency of a cytotoxic drug. Thirteen ADCs, utilizing seven unique cytotoxic payloads and targeting 11 distinct antigens, are currently approved by the US Food and Drug Administration as of June 2025, representing a rapidly growing and highly promising class of anticancer ...
Sijie Lu, Qingqing Xiao, Lixuan Qian, Siyuan Sun, Zhu Zhou, Michael Z. Liao, Chunze Li   +6 more
wiley   +1 more source